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Assessment of Canine Pancreas-Specific Lipase and Outcomes in
Dogs with Hemodialysis-Dependent Acute Kidney Injury
K. Takada , C.A. Palm , S.E. Epstein, and L.D. Cowgill
Background: Renal replacement therapies can be life-saving for dogs with severe acute kidney injury (AKI), however, comorbidities
including pancreatitis might affect outcome.
Hypothesis/Objectives: To investigate the prevalence of pancreas-specific lipase (Spec cPL) measurements consistent with pancreatitis
(400 lg/L) in dogs undergoing intermittent hemodialysis (IHD) for treatment of AKI and to determine whether there were
associations between 30-days outcomes and Spec cPL measurements.
Animals: Fifty-three client-owned dogs presented to teaching hospitals between November 2008 and September 2016 that underwent IHD.
Methods: Retrospective medical record review from dogs that received IHD for management of AKI and also had a Spec cPL
measurement. Association between survival, dialysis-dependency, and Spec cPL measurements was assessed.
Results: Forty of 53 (76%) dogs were alive at 30-days and 33/53(62%) had a Spec cPL result 400 lg/L. Spec cPL was not significantly
different either between surviving (635.5 lg/L, range 29–1,001) and nonsurviving dogs (860 lg/L, range 56–1,001; P5 0.75) or
between dialysis-dependent (1,001 lg/L, range 177–1,001) and nondialysis-dependent dogs (520 lg/L, range 29–1,001; P5 0.08).
Spec cPL 400 lg/L was not significantly associated either with survival (P5 0.74) or dialysis-dependency (P5 0.33).
Conclusions and Clinical Importance: Results revealed a high prevalence of Spec cPL 400 lg/L in dogs with AKI treated with IHD.
No significant associations between Spec cPL and survival or dialysis-dependency in dogs with AKI at 30 days were identified in the
current study, however, the latter could be due to lack of power in this study.
Key words: Canine specific pancreatic lipase; Kidney failure; Renal recovery; Renal replacement therapy.
A cute kidney injury (AKI) is a common condition in ani-mals that can be associated with morbidity and death.
AKI represents a spectrum of disease severity ranging from
clinically nondetectable to life-threatening kidney disease.1,2
Dogs with severe grades of AKI and fulminant kidney failure
can require renal replacement therapy (RRT) for successful
management.3,4 The decision to initiate RRT requires a consid-
erable emotional and financial commitment for pet owners,
especially because often it is difficult to determine prognosis
at the onset of therapy. This inability to prognosticate is in part
due to the varied etiologies and co-morbidities associated with
AKI that can have different outcomes, as well as the limited
reports detailing objective outcome data for dogs with AKI
undergoing RRT.5–7 In human medicine, outcome studies
evaluating AKI, including the association of AKI with various
co-morbidities including acute pancreatitis (AP) are exten-
sive8,9 and similar studies in veterinary medicine are lacking.
Acute pancreatitis is a common co-morbidity associated
with AKI in dogs.10 It can be both a cause of AKI, as well
as a secondary consequence of AKI.11,12 Despite this associ-
ation, the impact of AP on renal recovery from AKI is not
known in veterinary medicine. However, it is well estab-
lished that inflammatory cytokines associated with AP can
compromise renal perfusion, promote apoptosis of the tubu-
lar epithelium, and likely delay renal recovery.13–15 Cur-
rently, serum specific pancreatic lipase (Spec cPL Test)
measured by ELISA is the most commonly used biomarker
for diagnosis of pancreatitis in dogs.16,17 Spec cPL has good
overall clinical diagnostic performance in diagnosing AP
with a high sensitivity and specificity for the diagnosis of
AP in clinical settings in dogs. Reported sensitivities for
moderate to severe pancreatitis using the cut-off value of
400 lg/L range from 70 to 77% and specificities range from
78 to 88%.18–21
We hypothesized that Spec cPL results consistent with a
diagnosis of pancreatitis would be negatively associated
with survival in dogs with dialysis-dependent AKI, and ele-
vated Spec cPL values would be associated with prolonged
dialysis-dependency. The aims of this study were to deter-
mine the prevalence of Spec cPL results 400 lg/L in dogs
undergoing RRT for treatment of AKI and the association
between Spec cPL and outcomes in these dogs.
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Materials and Methods
Medical records were reviewed retrospectively to identify dogs that
were admitted to the University of California-Davis William R. Pritch-
ard Veterinary Medical Teaching Hospital and the University of Cali-
fornia Veterinary Medical Center-San Diego between November 2008
and September 2016. Inclusion criteria were dogs with AKI managed
by intermittent hemodialysis (IHD), that also had at least one Spec cPL
measurement performed within 7 days before or after the first admis-
sion to our institutions. Data collected included signalment, date of
admission, dates of initiation and discontinuation of hemodialysis,
serum creatinine values at presentation (iSCre; initial serum creatinine
concentration),a Spec cPL values, date of Spec cPL measurement and
information regarding survival and dialysis dependency at 30 days after
admission. Diagnosis of AKI was done by the attending clinician, and
in general, was based on history, acute onset of clinical signs, progres-
sive renal azotemia, and consistent findings on urinalysis and abdomi-
nal ultrasound. Post-renal azotemia, acute nephrotoxin ingestion
without azotemia, and dogs that had been diagnosed previously with
chronic kidney disease were excluded. Initiation of RRT was made at
the discretion of the attending clinician. IHD treatments were also dis-
continued at the discretion of the attending clinician(s) when dogs could
be maintained without RRT (typically when serum creatinine values
were less than 5.0 mg/dL without RRT) or when owners elected for dis-
continuation because of financial or quality-of-life factors.
If information was available regarding survival status of dogs at 30
days after admission, they were included in the analysis. Animals were
classified as alive or dead at 30 days after admission. Dogs classified in
the dead group included dogs that died during hospitalization for AKI
or were euthanized. If dogs were alive at 30 days, they were further
classified as dialysis-dependent or nondialysis-dependent. Dogs were
classified as dialysis-dependent if they required IHD for ongoing man-
agement to maintain creatinine values of <5 mg/dL at 30 days. If IHD
treatments were discontinued based on improved kidney function and
residual kidney function resulted in a creatinine <5 mg/dL, the dog was
categorized to be nondialysis-dependent from the day after the last dial-
ysis treatment. If the owner elected to discontinue the dialysis before
recommended by the attending clinician, the dog was categorized into
the dialysis-dependent group, provided the creatinine remained 5 mg/
dL at 7 days or more after discontinuation of IHD.
The Spec cPL assay was performed by a monoclonal antibody sand-
wich ELISA as previously described.21 According to the manufacturer,
the reference interval is 0–200 lg/L, 201–399 lg/L is considered in the
equivocal or “grey” zone, and 400 lg/L is consistent with pancreati-
tis.b Values of Spec cPL less than the detection limit and reported as
<30 lg/L were assigned values of 29 lg/L for statistical analysis. Val-
ues of Spec cPL greater than 1,000 lg/L were assigned a value of 1,001
lg/L for statistical analysis. For cases with more than one Spec cPL
measurement during the course of AKI, the first measurement was used
for analysis. In this study, the decisions to measure Spec cPL were
made by each attending clinician in accordance with clinical signs sug-
gestive for pancreatitis, however, all dogs at the University of
California-Davis William R. Pritchard Veterinary Medical Teaching
Hospital have Spec cPL measurements made when undergoing RRT, to
aid in medical management decision making, given the difficulty to dis-
tinguish AKI dogs with or without AP based on the clinical signs. Spec
cPL values 400 lg/L were categorized as positive or consistent with a
diagnosis of pancreatitis based on the laboratory reference intervals
developed by the manufacturer.
Statistical Methods
Descriptive data are presented as percentages, median, and range.
The Mann-Whitney U-test was used for comparison of the distribution
between groups for Spec cPL values. Categorical data were compared
with groups either between alive and dead dogs or between dialysis-
dependent and nondialysis-dependent dogs by a Fisher’s exact test. A
value of P< 0.05 was considered significant. All analyses were per-
formed with statistical software.c
Results
One hundred fifty-four dogs were identified for possible
inclusion based on undergoing IHD for treatment of AKI.
Among those, 101 dogs were excluded due to lack of Spec
cPL measurement (n5 91) or because Spec cPL measure-
ment was not performed within 7 days of admission to our
hospitals (n5 9). Fifty-three dogs were enrolled for the
analysis in this study.
Median age of all dogs was 7.1 years (range: 0.7–14.5
years). Nineteen dogs were neutered male, 21 were spayed
female, 9 were intact male, and 4 were intact female.
Median iSCre value at presentation was 9.4 mg/dL (range:
3.4–16.6 mg/dL). Overall, 33/53 (62%) of dogs had Spec
cPL values 400 lg/L, consistent with pancreatitis, and 10/
53 (19%) of dogs were considered to be in “grey-zone” with
Spec cPL values between 200 and 399 lg/L. All included
dogs had clinical signs, such as vomiting, nausea, and
abdominal pain, which could have been consistent with
AKI, acute pancreatitis, or both diseases concurrently.
At 30 days from admission, 40/53 (76%) dogs were still
alive. Of the 40 surviving dogs, 14 (35%) dogs were further
classified as dialysis-dependent and 26/40 (65%) were clas-
sified as nondialysis-dependent. Twenty-six of 40 surviving
dogs had IHD discontinued due to improvement as
described above. One of 40 surviving dogs had IHD discon-
tinued based on the attending clinician’s decision, however,
the creatinine value progressed to 6.3 mg/dL with discontin-
uation of IHD. Due to the progressive azotemia, this dog
was classified in the dialysis-dependent group based on the
study criteria above. All other dogs in which IHD was dis-
continued had sufficient residual kidney function to main-
tain creatinine <5 mg/dL and were therefore classified in
the nondialysis-dependent group.
The median Spec cPL value for the dialysis-dependent
group was 1,001 lg/L (range: 177–1,001 lg/L) and for the
nondialysis-dependent group was 520 lg/L (range: 29–
1,001 lg/L) (Fig 1). There was no significant difference in
Spec cPL between dialysis-dependent and nondialysis-
dependent groups (P5 0.08).
At 30 days from admission, 13/53 (25%) dogs died or
were euthanized. Four of 13 dogs in the nonsurvival group
died; one dog died from shock after development of disse-
minated intravascular coagulation, one dog developed car-
diopulmonary arrest during an IHD treatment, one dog
developed cardiopulmonary arrest in the ICU, and the final
dog developed cardiopulmonary arrest during a procedure
unrelated to dialysis. Nine of 13 dogs were euthanized at the
owner’s request. Reasons for euthanasia included poor
quality-of-life or poor prognosis due to progressive concur-
rent disease (n5 5), lack of renal recovery despite dialytic
management of uremia (n5 2), and owner financial limita-
tions (n5 2). The 4 latter cases were stable at the time of
euthanasia and were euthanized a median of 15 days (range:
6–24 days) from initial admission.
Median Spec cPL values for the survival and nonsurvival
groups were 636? lg/L (range: 29–1,001 lg/L) and 860 lg/
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L (range: 56–1,001 lg/L), respectively (Fig 2). There was
no statistically significant difference in Spec cPL values
between these two groups (P5 0.75).
The distribution of dogs with or without Spec cPL results
400 lg/L was assessed according to their dialysis-
dependency at 30 days. Among 14 dialysis-dependent dogs,
10/14 (71%) had Spec cPL results consistent with a diagno-
sis of pancreatitis, and 8/10 (80%) had a Spec cPL result of
>1,000 lg/L. Among nondialysis-dependent dogs, 14/26
(54%) had Spec cPL results consistent with a diagnosis of
pancreatitis, and 7/14 (50%) had a Spec cPL result of
>1,000 lg/L. There was no statistical difference regarding a
positive Spec cPL (400 lg/L) consistent with pancreatitis
and dialysis-dependency (P5 0.33).
Overall, 33/53 (62%) dogs had Spec cPL values (400
lg/L), consistent with pancreatitis. Among the 40 dogs alive
at 30 days after admission, 24/40 (60%) had Spec cPL
results consistent with a diagnosis of pancreatitis, whereas,
of 13 nonsurviving dogs, 9/13 (70%) had spec cPL results
consistent with a diagnosis of pancreatitis. There was no
statistically significant difference between dogs either with
or without positive (400 lg/L) Spec cPL result regarding
survival (P5 0.74).
Discussion
Our study evaluates the association between Spec cPL
and the outcome of dogs with dialysis-dependent AKI.
Based on Spec cPL increases in conjunction with clinical
assessment, a high prevalence of pancreatitis (62%) was
documented in the dogs undergoing IHD for treatment of
AKI in this study. In addition, Spec cPL results consistent
with a diagnosis of pancreatitis based on the current cut-off
recommendations were not significantly associated with
survival or dialysis-dependency at 30 days in this cohort of
dogs.
In a previous report, pancreatitis was the most common
co-morbidity in dogs with AKI but that study did not
include dogs managed with IHD and did not report out-
comes after discharge from the hospital.10 In the study refer-
enced above, the Spec cPL assay was not available, and the
criteria for the diagnosis of AP were not specified.10 Given
the high prevalence of AP in dogs with AKI, it is beneficial
to understand the potential impact on dogs undergoing RRT
for treatment of AKI so outcomes can be better understood.
In the current study, at 30 days after admission, 76% of
dogs in this cohort were still alive. This survival rate is
higher than previous reports of a 51–53% survival for AKI
managed with RRT.5–7 The possible explanations for this
discrepancy could be case selection, definition of survival,
and underlying etiologies for AKI. For example, in our
study, cases lacking Spec cPL measurements were
excluded, and this might have led to bias with case
selection.
There were no statistically significant differences in Spec
cPL values between the survival and nonsurvival groups,
and based on these results, the presence or absence of AP
should not be considered as a negative prognostic indicator
for the dogs with AKI undergoing RRT. In human medicine,
it is reported that AP followed by hospital-acquired AKI
leads to decreased survival rates,22–24 however, no dog in
our study developed hospital acquired AKI secondary to
AP. This discrepancy might be due to euthanasia of dogs
with severe AP before development of AKI or due to other
species-specific differences in pathophysiology. In addition,
in dogs with elevated Spec cPL values, it is difficult to
definitively determine if AP was truly present, and if pres-
ent, if AP was a consequence of, or a cause of AKI.
Among the surviving dogs, Spec cPL values did not show
a significant difference between dialysis-dependent and
nondialysis-dependent dogs at 30 days from initial admis-
sion. This finding suggests that an elevated Spec cPL might
not be a negative prognostic indicator for dogs with AKI
undergoing IHD. Given the large discrepancy in median
Spec cPL values between the dialysis-dependent and
nondialysis-dependent groups, however, it is possible that
larger case numbers and the ability to more accurately
Fig 2. Whisker box plot comparing canine specific pancreatic lipase
values between dead (n5 13) and alive (n5 40) dogs. The vertical
boundaries of the box represent the first and third quartiles of that
data series, and the horizontal line in the box represent the median
values. No statistically significant difference was detected. (P5 0.75).
Fig 1. Whisker box plot comparing canine specific pancreatic lipase
values between dialysis-dependent (n5 14) and nondialysis-dependent
(n5 26) dogs. The vertical boundaries of the box represent the first
and third quartiles of that data series, and the horizontal line in the
box represent the median values. No statistically significant difference
was detected. (P5 0.08).
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define absolute Spec cPL values between 1,000 and 2,000
lg/L might have resulted in a significant association
between Spec cPL and dialysis dependency.
Despite the lack of significant differences in Spec cPL
between groups, the highest proportion (8/10, 80%) of the
extremely high Spec cPL values (>1,000 lg/L) was
obtained in the dialysis-dependent group, whereas only 7/
14 (50%) of dogs had the same degree of Spec cPL results
in the nondialysis-dependent group. As depicted in Fig 1,
while significant results were not identified, it is possible
that lack of power might have prevented significance. This
could suggest that the presence of more severe pancreatitis
might cause slower renal recovery and might correlate
with a longer course of disease. It is important to note the
possibility that higher Spec cPL values could correlate
with more severe decreases in endogenous urinary clearan-
ces, not representative of true pancreatic inflammation.
However, a previous report showed no significant associa-
tion between severity of AKI as defined by degree of creat-
inine elevation, and Spec cPL elevation. no significant
association between severity of AKI and Spec cPL eleva-
tion.25 Further studies and larger case numbers are war-
ranted, but it is possible a specific Spec cPL cut-off
predicting prolonged dialysis dependency due to AP might
be able to be established.
The retrospective nature of this study imposes several
limitations. First, the case numbers in each group were rela-
tively small and might have led to the nonsignificant results
of this study. For the extremely high Spec cPL results
(>1,000 lg/L), the exact values were not possible to be
obtained at the time when this study was conducted, and
this also might have led to the nonsignificant results of this
study. The time points for Spec cPL measurement were not
uniform for all dogs. Some samples were submitted by the
referring veterinarian before referral to our institution, and
some samples were submitted after initiation of RRT. This
lack of precise timing of Spec cPL measurement could
influence the accuracy of establishing a definitive diagnosis
of AP. In addition, Spec cPL was used to predict AP, and
biopsy samples were not obtained for the confirmation in
any case. The influence of IHD on Spec cPL values is also
unknown, however, canine pancreatic lipase was reported to
have a molecular weight of approximately 50.7 kDa, and
unlikely to be influenced by the clearance of the hemodialy-
sis due to its large size.26,27 Dogs included in the study also
had variable etiologies causing AKI, which might have
affected outcomes beyond the effect of Spec cPL. Lastly,
only initial Spec cPL results were included for the analysis,
and it is possible that AP could have developed in hospital
and might have not been diagnosed at the time of the initial
measurement, or that depending on attending clinician’s
assessment, cases could have been pre-selected to measure
Spec cPL at the time of admission to the hospital; the latter
is less likely, as all cases undergoing IHD at the University
of California-Davis William R. Pritchard Veterinary Medi-
cal Teaching Hospital have Spec cPL measurements per-
formed to aid in medical management, primarily in dietary
prescriptions. To address these limitations, a multicentric
prospective study with sequential Spec cPL concentrations
is warranted.
In conclusion, this report showed a high prevalence of
elevated Spec cPL values in the dogs with AKI treated with
RRT. A positive Spec cPL result consistent with a diagnosis
of pancreatitis (400 lg/L) was not associated with out-
comes prediction of survival or dialysis-dependency at 30
days of admission in this cohort of dogs. Severe AP as pre-
dicted by Spec cPL >1,000 lg/L might influence recovery
of kidney function in dogs with AKI or influence the dura-
tion of dialysis-dependency.
Footnotes
a VMTH Clinical Diagnostic Laboratory Services, University of
California-Davis, Davis, CA
b IDEXX Laboratories Inc, Sacramento, CA
c GraphPad Prism 6.0 for Mac, GraphPad Software Inc, La Jolla, CA
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